Jennison Associates’s Inovio Pharmaceuticals INO Stock Holding History

Jennison Associates’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-26,042	Closed	-$4.16M	–	737
2014 Q1	$4.16M	Buy	+26,042	New	+$3.74M	﹤0.01%	526

Other funds holding INO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates's INO Position: Q2 2014 in Review

Jennison Associates sold out of Inovio Pharmaceuticals (INO) in Q2 2014, closing a stake of 26,042 shares — an estimated $4.16M sold.

Jennison Associates first reported a position in INO in Q1 2014 and held it in 1 quarter. The position peaked at $4.16M in Q1 2014. 76 funds tracked by Wall St. Rank hold INO as of Q2 2014.

Jennison Associates reported no remaining Inovio Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
Jennison Associates sold 26,042 Inovio Pharmaceuticals shares in Q2 2014, an estimated $4.16M.
Jennison Associates first reported a position in Inovio Pharmaceuticals in Q1 2014 and held it in 1 quarter.
Jennison Associates's Inovio Pharmaceuticals position peaked at $4.16M in Q1 2014.
76 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2014.

Based on Jennison Associates's 13F filing for Q2 2014, filed 8 Aug 2014.